SCHEMBL8097057

SCHEMBL8097057

[CH2]C([CH2])Cn1cnc2c(=O)[nH]c(N)nc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNP P00491 4/20 0.60
TK1 P04183 2/20 0.60
BLM P54132 2/20 0.60
MEN1 O00255 1/20 0.60
ALDH1A1 P00352 1/20 0.60
LMNA P02545 1/20 0.60
CYP3A4 P08684 1/20 0.60
NFKB1 P19838 1/20 0.60
VCP P55072 1/20 0.60
KMT2A Q03164 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
HIF1A Q16665 1/20 0.60
HPRT1 P00492 12/20 0.59
USP2 O75604 1/20 0.59
TSHR P16473 1/20 0.59
EDNRA P25101 1/20 0.59
HTR2A P28223 1/20 0.59
RECQL P46063 1/20 0.59
HBB P68871 1/20 0.59
HSD17B10 Q99714 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5503495 0.86 PNP (0.60) PNPTK1BLMMEN1ALDH1A1
SCHEMBL20723337 0.84 PNP (0.60) PNPTK1BLMMEN1ALDH1A1
SCHEMBL7268685 0.83 HPRT1 (0.61) PNPTK1BLMMEN1ALDH1A1
SCHEMBL7262066 0.83 HPRT1 (0.61) PNPTK1BLMMEN1ALDH1A1
Tiviciclovir SCHEMBL6944256 0.83 BLM (0.67) PNPTK1BLMMEN1ALDH1A1
SCHEMBL7262060 0.83 HPRT1 (0.61) PNPTK1BLMMEN1ALDH1A1
SCHEMBL9960816 0.83 PNP (0.68) PNPTK1BLMMEN1ALDH1A1
SCHEMBL29286376 0.83 TK1 (0.76) PNPTK1BLMHPRT1USP2
SCHEMBL15054517 0.83 HPRT1 (0.57) PNPTK1BLMMEN1ALDH1A1
SCHEMBL23710631 0.82 HPRT1 (0.67) PNPTK1BLMMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083953-A Treating herpes simplex virus or cytomegalovirus infections; valganciclovir hydrochloride in crystalline form; antiviral; oral administration SYNTEX (U.S.A.) INC. (US) 2000-07-04 US disclosed